Your browser doesn't support javascript.
loading
Racial/Ethnic Disparities in Substance Use Treatment in Medicaid Managed Care in New York City: The Role of Plan and Geography.
Alegría, Margarita; Falgas-Bague, Irene; Fukuda, Marie; Zhen-Duan, Jenny; Weaver, Cole; O'Malley, Isabel; Layton, Timothy; Wallace, Jacob; Zhang, Lulu; Markle, Sheri; Lincourt, Pat; Hussain, Shazia; Lewis-Fernández, Roberto; John, Dolly A; McGuire, Thomas.
Affiliation
  • Alegría M; Disparities Research Unit, Massachusetts General Hospital.
  • Falgas-Bague I; Departments of Medicine.
  • Fukuda M; Psychiatry.
  • Zhen-Duan J; Disparities Research Unit, Massachusetts General Hospital.
  • Weaver C; Departments of Medicine.
  • O'Malley I; Disparities Research Unit, Massachusetts General Hospital.
  • Layton T; Disparities Research Unit, Massachusetts General Hospital.
  • Wallace J; Departments of Medicine.
  • Zhang L; Health Care Policy, Harvard Medical School, Boston, MA.
  • Markle S; Disparities Research Unit, Massachusetts General Hospital.
  • Lincourt P; Health Care Policy, Harvard Medical School, Boston, MA.
  • Hussain S; Yale School of Public Health, New Haven, CT.
  • Lewis-Fernández R; Disparities Research Unit, Massachusetts General Hospital.
  • John DA; Disparities Research Unit, Massachusetts General Hospital.
  • McGuire T; New York State Office of Alcoholism and Substance Abuse Services, Albany.
Med Care ; 60(11): 806-812, 2022 11 01.
Article in En | MEDLINE | ID: mdl-36038524
ABSTRACT

OBJECTIVE:

The aim was to assess the magnitude of health care disparities in treatment for substance use disorder (SUD) and the role of health plan membership and place of residence in observed disparities in Medicaid Managed Care (MMC) plans in New York City (NYC). DATA SOURCE Medicaid claims and managed care plan enrollment files for 2015-2017 in NYC. RESEARCH

DESIGN:

We studied Medicaid enrollees with a SUD diagnosis during their first 6 months of enrollment in a managed care plan in 2015-2017. A series of linear regression models quantified service disparities across race/ethnicity for 5 outcome indicators treatment engagement, receipt of psychosocial treatment, follow-up after withdrawal, rapid readmission, and treatment continuation. We assessed the degree to which plan membership and place of residence contributed to observed disparities.

RESULTS:

We found disparities in access to treatment but the magnitude of the disparities in most cases was small. Plan membership and geography of residence explained little of the observed disparities. One exception is geography of residence among Asian Americans, which appears to mediate disparities for 2 of our 5 outcome measures.

CONCLUSIONS:

Reallocating enrollees among MMC plans in NYC or evolving trends in group place of residence are unlikely to reduce disparities in treatment for SUD. System-wide reforms are needed to mitigate disparities.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Medicaid / Substance-Related Disorders Type of study: Guideline / Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Med Care Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Medicaid / Substance-Related Disorders Type of study: Guideline / Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Med Care Year: 2022 Document type: Article